Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamidronate for diffuse sclerosing osteomyelitis of the jaw
jRCTs011180002Active, not recruiting
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of pamidronate in Diffuse sclerosing osteomyelitis of the jaw (DSO). Primary endpoint: Change in pain VAS. Started Jul 2018; status: active, not recruiting.
02
Drugs
pamidronate
03
Conditions
Diffuse sclerosing osteomyelitis of the jaw (DSO)
Beyond the preview
Go deeper on jRCTs011180002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs011180002.